If you have upper motor neuron lesions, you have damage to certain nerve cells that help you move. Medicines and therapy can help control symptoms like muscle spasms and help you walk and talk more ...

Novartis wins FDA approval for Itvisma, a one-time gene therapy offering broader SMA treatment with sustained motor function ...

One of the most important functions of interneurons in the knee-jerk reflex is to mediate reciprocal inhibition. This process ensures that the contraction of the quadriceps muscle is accompanied by ...

The FDA has approved Itvisma for the treatment of children two years and older, teens and adults living with spinal muscular ...

U.S. Food and Drug Administration has approved Novartis' gene therapy for a type of rare muscle disorder, the drugmaker said ...

Former England rugby captain Lewis Moody has been diagnosed with motor neurone disease (MND). The 47-year-old flanker, who won several titles throughout his 16-year career, discovered he had the ...

Novartis secured approval for its drug to treat certain patients diagnosed with spinal muscular atrophy from the Food and Drug Administration.

A new medicine, discovered by scientists, protects nerve cells damaged by motor neurone disease (MND), offering hope of ...

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study. MND is a group of rare ...

Scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a ...

The therapy, branded as Itvisma, was approved for the treatment of spinal muscular atrophy patients of age two years and ...